Acadia Pharmaceuticals buy Citigroup Inc.
Start price
08.08.24
/
50%
€14.56
Target price
08.08.25
€21.06
Performance (%)
43.94%
End price
09.08.25
€20.95
Summary
This prediction ended on 09.08.25 with a price of €20.95. The BUY prediction by Citigroup_Inc_ for Acadia Pharmaceuticals saw massive gains of 43.94%. Citigroup_Inc_ has a follow-up prediction for Acadia Pharmaceuticals where he still thinks Acadia Pharmaceuticals is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Acadia Pharmaceuticals | -5.144% | -5.144% | 44.823% |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Citigroup Inc. from $30.00 to $23.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
In the thread Trading Acadia Pharmaceuticals
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Acadia Pharmaceuticals
Stopped prediction by Citigroup_Inc_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.59
09.05.24
09.05.24
€27.83
09.05.25
09.05.25
8.26%
10.05.25
10.05.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.00
13.12.23
13.12.23
€35.17
13.12.24
13.12.24
-17.60%
14.12.24
14.12.24